AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Pharmaceutical Preparations

Showing 291 to 300 of 478 articles

Clear Filters

Hidden bias in the DUD-E dataset leads to misleading performance of deep learning in structure-based virtual screening.

PloS one
Recently much effort has been invested in using convolutional neural network (CNN) models trained on 3D structural images of protein-ligand complexes to distinguish binding from non-binding ligands for virtual screening. However, the dearth of reliab...

A Lightweight API-Based Approach for Building Flexible Clinical NLP Systems.

Journal of healthcare engineering
Natural language processing (NLP) has become essential for secondary use of clinical data. Over the last two decades, many clinical NLP systems were developed in both academia and industry. However, nearly all existing systems are restricted to speci...

Artificial Intelligence in Drug Treatment.

Annual review of pharmacology and toxicology
The most common applications of artificial intelligence (AI) in drug treatment have to do with matching patients to their optimal drug or combination of drugs, predicting drug-target or drug-drug interactions, and optimizing treatment protocols. This...

Advancing Drug Discovery via Artificial Intelligence.

Trends in pharmacological sciences
Drug discovery and development are among the most important translational science activities that contribute to human health and wellbeing. However, the development of a new drug is a very complex, expensive, and long process which typically costs 2....

Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning.

Scientific reports
Blood-Brain-Barrier (BBB) is a strict permeability barrier for maintaining the Central Nervous System (CNS) homeostasis. One of the most important conditions to judge a CNS drug is to figure out whether it has BBB permeability or not. In the past 20 ...

Drug repositioning of herbal compounds via a machine-learning approach.

BMC bioinformatics
BACKGROUND: Drug repositioning, also known as drug repurposing, defines new indications for existing drugs and can be used as an alternative to drug development. In recent years, the accumulation of large volumes of information related to drugs and d...

In silico prediction of drug-induced rhabdomyolysis with machine-learning models and structural alerts.

Journal of applied toxicology : JAT
Drug-induced rhabdomyolysis (DIR) is a serious adverse reaction and can be fatal. In the present study, we focused on the modeling and understanding of the molecular basis of DIR of small molecule drugs. A series of machine-learning models were devel...

Drug Analogs from Fragment-Based Long Short-Term Memory Generative Neural Networks.

Journal of chemical information and modeling
Several recent reports have shown that long short-term memory generative neural networks (LSTM) of the type used for grammar learning efficiently learn to write Simplified Molecular Input Line Entry System (SMILES) of druglike compounds when trained ...

GuacaMol: Benchmarking Models for de Novo Molecular Design.

Journal of chemical information and modeling
De novo design seeks to generate molecules with required property profiles by virtual design-make-test cycles. With the emergence of deep learning and neural generative models in many application areas, models for molecular design based on neural net...

Shape-Based Generative Modeling for de Novo Drug Design.

Journal of chemical information and modeling
In this work, we propose a machine learning approach to generate novel molecules starting from a seed compound, its three-dimensional (3D) shape, and its pharmacophoric features. The pipeline draws inspiration from generative models used in image ana...